Company name:

CareDx Inc

  • IPO SHARE PRICE:
    $10.00
  • IPO DATE:
    July 17, 2014
  • TICKER:
    CDNA
  • MAIN STOCK EXCHANGE:
    NASDAQ
  • CURRENT HQ LOCATION:
    1 Tower Place South San Francisco California 94080
  • FISCAL YEAR END:
    December 31
  • INCORPORATION JURISDICTION:
    DE
  • ORGANIZED AS THE FOLLOWING LEGAL TYPE:
    Corporation
  • Investor Relations Webpage:
    Coming soon!
  • TAX RATE:
    USA federal corporate nominal income tax rate is 21%

Short Description

CareDx Inc

We are working hard and as soon as possible to provide company description soon. Feel free to reach out to request it sooner: improve@real-clear-investing.com

Income Statement

Quarterly Annual
(USD in thousand)
Selected Year:
31-Dec
2020
Revenue
Gross receipts in the form of cash (great!) and promises to pay (Account Receivables - not so great as some of them will never be collected but reality of business!) from all its customers
100%
85.1% —

Testing services revenue

10.0% —

Product revenue

4.8% —

Digital and other revenue
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Testing services revenue
45,679
45,679
45,679
45,679
45,679
 33,106 60,300 104,550 163,610 163,610 201,384
Product revenue
-
-
$45,679
$45,679
$45,679
 14,634 15,674 18,279 19,302 19,302 23,732
Collaboration and license revenue
$45,679
$45,679
$45,679
$45,679
-
 - - - - - -
Digital and other revenue
-
-
-
-
-
 584 595 4,239 9,282 9,282 9,460
License and other revenue
-
-
-
-
$45,679
 - - - - - -
Total Revenue
$45,679
$45,679
$45,679
$45,679
$45,679
 $48,324 $76,569 $127,068 $192,194 $192,194 $234,576
Selected Year:
31-Dec
2020
Operating expenses
Cost (labor, materials, depreciation, overhead, etc) for delivering service or manufacturing a product that business sells
111.7%
28.0% —

Sales and marketing

25.5% —

Research and development

25.4% —

General and administrative

22.9% —

Cost of testing services

7.2% —

Cost of product

2.8% —

Cost of digital and other
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Cost of revenue
-
-
-
-
-
 21,371 32,987 45,455 - - -
Cost of testing services
45,679
45,679
45,679
45,679
45,679
 - 21,456 29,622 43,932 43,932 53,204
Cost of product
-
-
45,679
45,679
45,679
 - 11,531 12,919 13,847 13,847 16,848
Cost of digital and other
-
-
-
-
-
 - - 2,914 5,338 5,338 5,488
Gross profit
-
-
-
-
-
 $26,953 $43,582 $81,613 - - -
Sales and marketing
45,679
45,679
45,679
45,679
45,679
 12,808 21,670 38,894 53,858 53,858 64,524
Research and development
45,679
45,679
45,679
45,679
45,679
 12,388 14,514 30,711 48,941 48,941 53,300
General and administrative
45,679
45,679
45,679
45,679
45,679
 20,093 22,976 36,540 48,806 48,806 53,480
Goodwill impairment
-
-
45,679
45,679
45,679
 1,958 - - - - -
Change in estimated fair value of contingent consideration Change in estimated fair value of contingent consideration
45,679
45,679
45,679
45,679
45,679
 - - - - - -
Total operating expenses
45,679
45,679
45,679
45,679
45,679
 47,247 92,147 151,600 214,722 214,722 246,844
Selected Year:
31-Dec
2020
Operating Income
Income after excluding Operating Expenses from Total Revenue
11.7%
11.7% —

Operating Income

Key metric that shows earnings potential of the company's business model
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Operating income
$45,679
$45,679
$45,679
$45,679
$45,679
 ($20,294) ($15,578) ($24,532) ($22,528) ($22,528) ($12,268)
Selected Year:
31-Dec
2020
Non-operating expenses
Cost usually unrelated to delivering service or manufacturing a product that business sells
1.3%
2.5% —

CARES Act Provider Relief Fund

0.0% —

Early repayment of debt expenses

0.4% —

Other expense net

0.8% —

Change in estimated fair value of common stock warrant and derivative liability
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Change in estimated fair value of common stock warrant and derivative liability
-
-
45,679
45,679
45,679
 (29,622) (22,978) 319 (1,495) (1,495) -
CARES Act Provider Relief Fund
-
-
-
-
-
 - - - 4,813 4,813 -
Other expense or income
45,679
45,679
45,679
-
-
 - - - - - -
Other expense net
-
-
-
45,679
45,679
 (1,031) (178) (719) (811) (811) (956)
Early repayment of debt expenses
-
-
-
-
45,679
 (459) (5,780) - - - -
Total non-operating income (expense)
45,679
45,679
45,679
45,679
45,679
 (31,112) (28,936) (400) 2,507 2,507 (956)
Selected Year:
31-Dec
2020
Earnings before Interest and Taxes (EBIT)
Income after excluding Operating and Non-operating Expenses from Total Revenue
10.4%
10.4% —

EBIT

Another income metric but unlike Operating Income it is closer to the ultimate income metric - Net Income by removing expenses that are not related to earning Revenue as they are supposed to be accidental and transitory
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
EBIT
$45,679
$45,679
$45,679
$45,679
$45,679
 ($51,406) ($44,514) ($24,932) ($20,021) ($20,021) ($13,224)
Selected Year:
31-Dec
2020
Interest Expense and Income, Taxes
Expenses driven mostly by company management's choices, nature of business (capital intensive vs not) about financing (debt vs equity) and legal structure
0.7%
0.5% —

Income tax expense or benefit

0.1% —

Interest expense (income)
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Interest expense (income)
-
-
-
-
-
 (5,863) (3,701) 985 271 271 -
Interest expense
45,679
45,679
45,679
45,679
45,679
 - - - - - -
Total other expense or income
-
-
-
-
-
 (36,975) (32,637) 585 2,778 2,778 (2,476)
Income before income taxes
45,679
45,679
45,679
45,679
45,679
 (57,269) (48,215) (23,947) (19,750) (19,750) (14,744)
Income tax expense or benefit
45,679
45,679
45,679
45,679
45,679
 1,709 1,434 1,979 1,036 1,036 684
Selected Year:
31-Dec
2020
Net income (loss)
Ultimate measure of Income - Net result after excluding all expenses from Total Revenue
9.7%
9.7% —

Net income (loss)

It is a residue that is left from Total Revenue after paying all kind of expenses and belongs to all equity holders in the company. Some of these shareholders such Non-controlling interest or Preferred equity gets their share before Common shareholders
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Net income (loss)
$45,679
$45,679
$45,679
$45,679
$45,679
 ($55,560) ($46,781) ($21,968) ($18,714) ($18,714) ($14,060)
Net income (loss) attributable to non-controlling interests Net income (loss) attributable to non-controlling interests
-
-
45,679
45,679
45,679
 (91) (25) - - - -
Net income (loss) attributable to Company
-
-
45,679
45,679
45,679
 (55,469) (46,756) (21,968) (18,714) (18,714) -

Basic Shares Outstanding
Basic shares outstanding as of certain dates reported by Company on its annual and quarterly filings, these numbers are NOT used calculation of basic EPS. They help to see share issuance by company in perspective
Common
-
-
45,678,795
45,678,795
45,678,795
 29,074,603 41,728,442 42,879,426 51,822,662 51,822,662 51,822,662
Selected Year:
31-Dec
2020
EPS
Net Income / Shares Outstanding = EPS before dilution or Basic EPS; Net Income/ ( Shares Outstanding + potentially available shares from conversion of various option instruments)
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Net Income per basic share
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
 ($2.38) ($1.31) ($0.52) ($0.40) ($0.40) ($0.28)
Net Income per diluted share
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
$45,678,795.00
 ($2.38) ($1.31) ($0.52) ($0.40) ($0.40) ($0.28)